Biohit Oyj operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biohit Oyj with three other
pharmaceutical manufacturers in Europe:
Swedencare AB (publ)
sales of 99.14 million Swedish Kronor [US$9.95 million]
of which 67%
was PlaqueOff Powder),
(101.72 million Norwegian Kroner [US$11.09 million]
of which 100%
was Vitamin K2/MenaQ7), and
based in Russia
(774.10 million Russian Rubles [US$11.93 million]
Biohit Oyj reported sales of 9.90 million Euro (US$10.86 million)
December of 2018.
increase of 10.3%
versus 2017, when the company's sales were 8.98 million Euro.
Sales at Biohit Oyj have increased during each of the previous five years
(and since 2013, sales have increased a total of 187%).